학술논문

commerciallyAbiraterone and enzalutamide in the first line therapy of metastatic castration resistant prostate cancer
Document Type
Article
Source
In: Reports of Practical Oncology and Radiotherapy. (Reports of Practical Oncology and Radiotherapy, 2024, 29(1):1-9)
Subject
Language
English
ISSN
15071367